APT Medical Inc.

SHSE:688617 Stock Report

Market Cap: CN¥34.9b

APT Medical Future Growth

Future criteria checks 6/6

APT Medical is forecast to grow earnings and revenue by 28.8% and 29.1% per annum respectively. EPS is expected to grow by 23.9% per annum. Return on equity is forecast to be 29.7% in 3 years.

Key information

28.8%

Earnings growth rate

23.9%

EPS growth rate

Medical Equipment earnings growth25.8%
Revenue growth rate29.1%
Future return on equity29.7%
Analyst coverage

Low

Last updated17 Dec 2024

Recent future growth updates

Recent updates

Shareholders Would Enjoy A Repeat Of APT Medical's (SHSE:688617) Recent Growth In Returns

Oct 16
Shareholders Would Enjoy A Repeat Of APT Medical's (SHSE:688617) Recent Growth In Returns

Should You Be Adding APT Medical (SHSE:688617) To Your Watchlist Today?

Sep 19
Should You Be Adding APT Medical (SHSE:688617) To Your Watchlist Today?

More Unpleasant Surprises Could Be In Store For APT Medical Inc.'s (SHSE:688617) Shares After Tumbling 27%

Jul 25
More Unpleasant Surprises Could Be In Store For APT Medical Inc.'s (SHSE:688617) Shares After Tumbling 27%

APT Medical (SHSE:688617) Is Very Good At Capital Allocation

Jul 16
APT Medical (SHSE:688617) Is Very Good At Capital Allocation

Are APT Medical Inc. (SHSE:688617) Investors Paying Above The Intrinsic Value?

Jun 20
Are APT Medical Inc. (SHSE:688617) Investors Paying Above The Intrinsic Value?

APT Medical Inc. (SHSE:688617) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected

May 10
APT Medical Inc. (SHSE:688617) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected

APT Medical's (SHSE:688617) Promising Earnings May Rest On Soft Foundations

May 02
APT Medical's (SHSE:688617) Promising Earnings May Rest On Soft Foundations

APT Medical (SHSE:688617) Knows How To Allocate Capital Effectively

Apr 10
APT Medical (SHSE:688617) Knows How To Allocate Capital Effectively

Here's Why We Think APT Medical (SHSE:688617) Might Deserve Your Attention Today

Mar 19
Here's Why We Think APT Medical (SHSE:688617) Might Deserve Your Attention Today

Earnings and Revenue Growth Forecasts

SHSE:688617 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20263,7361,237N/A1,1203
12/31/20252,807929N/A9314
12/31/20242,132703N/A6534
9/30/20241,961659104728N/A
6/30/20241,863619117701N/A
3/31/20241,756571389687N/A
12/31/20231,650534487689N/A
9/30/20231,542501404572N/A
6/30/20231,448457352519N/A
3/31/20231,300394267417N/A
12/31/20221,216358224367N/A
9/30/20221,123306197371N/A
6/30/20221,000252103250N/A
3/31/202293322840206N/A
12/31/202182920814181N/A
9/30/202175020139164N/A
6/30/2021671186119223N/A
3/31/2021569149139200N/A
12/31/2020479111104148N/A
9/30/20204429361110N/A
12/31/201940483-1355N/A
12/31/201824222-1419N/A
12/31/201715334N/A13N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 688617's forecast earnings growth (28.8% per year) is above the savings rate (2.8%).

Earnings vs Market: 688617's earnings (28.8% per year) are forecast to grow faster than the CN market (25.3% per year).

High Growth Earnings: 688617's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 688617's revenue (29.1% per year) is forecast to grow faster than the CN market (13.4% per year).

High Growth Revenue: 688617's revenue (29.1% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 688617's Return on Equity is forecast to be high in 3 years time (29.7%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/18 14:13
End of Day Share Price 2025/01/17 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

APT Medical Inc. is covered by 11 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bo YuChina International Capital Corporation Limited
Yuan GaoChina International Capital Corporation Limited
Shuo SongCitic Securities Co., Ltd.